Therapix biosciences ltd. (TRPX)
Income statement / Quarterly
Jun'18Jun'17
Research and development expenses

650

455

General and administrative expenses

1,000

971

Total operating expense

1,650

1,426

Other expenses

0

0

Operating loss

-1,650

-1,426

Finance income

437

0

Finance expenses

1

437

Loss

-1,214

-1,863

Basic and diluted loss per share attributable to equity holders of the Company

0.01

0.03

Basic and diluted loss per ADS attributable to equity holders of the Company

0.35

1.10